EEG biomarkers observed in the mouse model of FXS, the Fmr1 KO mouse, are used to assess the efficacy of eCB system modulation as a potential therapeutic for cortical hyperexcitability in FXS. The gene discussed is FMR1; the disease is fragile X syndrome.